Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 14, 2019 - Issue
Submit an article Journal homepage
100
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol

Chad Moretz1 Glaxo Smith Kline, Research Triangle Park, Durham, NC, USACorrespondence[email protected]
,
Lindsay GS Bengtson2 Optum, Eden Prairie, MN, USA
,
Lucie Sharpsten2 Optum, Eden Prairie, MN, USA
,
Eleena Koep2 Optum, Eden Prairie, MN, USA
,
Lisa Le2 Optum, Eden Prairie, MN, USA
,
Junliang Tong2 Optum, Eden Prairie, MN, USA
,
Richard H Stanford1 Glaxo Smith Kline, Research Triangle Park, Durham, NC, USA
,
Beth Hahn1 Glaxo Smith Kline, Research Triangle Park, Durham, NC, USA
&
Riju Ray1 Glaxo Smith Kline, Research Triangle Park, Durham, NC, USA
 show all
Pages 2047-2060 | Published online: 04 Sep 2019

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gema Requena, Daniel Dedman, Jennifer K Quint, Rebecca E Ghosh, Rachael Williams & Jeanne M Pimenta. (2021) The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 629-642.
Read now
Chad Moretz, Ashley L Cole, George Mu, Benjamin Wu, Amy Guisinger, Yunhao Liu, Beth Hahn & Lee Baylis. (2020) Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2207-2215.
Read now

Articles from other publishers (5)

Wei-Chun Huang, Chih-Yu Chen, Wei-Chih Liao, Biing-Ru Wu, Wei-Chun Chen, Chih-Yen Tu, Chia-Hung Chen & Wen-Chien Cheng. (2022) Differences in Pulmonary Function Improvement after Once-Daily LABA/LAMA Fixed-Dose Combinations in Patients with COPD. Journal of Clinical Medicine 11:23, pages 7165.
Crossref
David Slade, Riju Ray, Chad Moretz, Guillaume Germain, François Laliberté, Qin Shen, Mei Sheng Duh, Malena Mahendran & Beth Hahn. (2021) Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study. BMC Pulmonary Medicine 21:1.
Crossref
Masato Muraki, Yuki Kunita, Ken Shirahase, Ryo Yamazaki, Soichiro Hanada, Hirochiyo Sawaguchi & Yuji Tohda. (2021) A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease. BMC Pulmonary Medicine 21:1.
Crossref
Shih-Lung Cheng. (2021) Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment. Journal of Clinical Medicine 10:12, pages 2649.
Crossref
Bernardino Alcázar-Navarrete & Jose Luis Lopez-Campos. (2020) Comparaciones entre asociaciones de broncodilatadores de larga duración para la enfermedad pulmonar obstructiva crónica. Open Respiratory Archives 2:4, pages 289-293.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.